Feiss P, Collet D, Vincelot A
Cah Anesthesiol. 1986 Mar-Apr;34(2):95-8.
The purpose of this study was the comparison of the effects on the labor and neonates of epidural analgesia conducted either with bupivacaine or 2-chloroprocaine. Hundred and three parturients were included in the study. They were randomly divided in two groups. Sixty-three patients received bupivacaine in 0.25% solution and 40 received 2-chloroprocaine in 2% solution. Epinephrine was not added to local anesthetics. The first dose was 25 mg of bupivacaine (10 ml) or 200 mg of 2-chloroprocaine (10 ml). Reinjections occurred every 30 min for 2-chloroprocaine (80 mg) and every hour for bupivacaine (10 mg). The time of onset of cutaneous analgesia was similar in both bupivacaine (12.5 +/- 4.7 min) and 2-chloroprocaine (13.8 +/- 5.1 min) patients. The incidence of incomplete or insufficient analgesia was significantly higher with 2-chloroprocaine. The number of parturients who required forceps for conclusion of childbirth was not statistically different with bupivacaine (n = 25, 40%) or 2-chloroprocaine (n = 11, 28%) (CHI2 = 1.5971, p = 0.2063). The second stage of labour was significantly longer in parturients who required forceps extraction in both groups. These patients also received significantly more local anesthetics. All newborns had an Apgar score performed before the third minute following birth. All observed Apgar scores except one of bupivacaine group were over eight. Umbilical cord blood was drawn for pH determination. Cord blood pH was slightly but significantly lower in bupivacaine (7.314 +/- 0.106) than in 2-chloroprocaine (7.345 +/- 0.06) patients (t = 1.6968, p = 0.046). Newborns extracted with forceps after maternal bupivacaine epidural analgesia had a significantly lower umbilical blood pH (7.278 +/- 0.117) than newborns who did not required forceps in the bupivacaine group (7.337 +/- 0.093) (t = 2.1986, p = 0.0159).(ABSTRACT TRUNCATED AT 250 WORDS)
本研究的目的是比较布比卡因或2-氯普鲁卡因用于硬膜外镇痛对产程及新生儿的影响。103名产妇纳入本研究。她们被随机分为两组。63例患者接受0.25%布比卡因溶液,40例接受2% 2-氯普鲁卡因溶液。局部麻醉药中未添加肾上腺素。首剂为25mg布比卡因(10ml)或200mg 2-氯普鲁卡因(10ml)。2-氯普鲁卡因每30分钟追加80mg,布比卡因每小时追加10mg。布比卡因组(12.5±4.7分钟)和2-氯普鲁卡因组(13.8±5.1分钟)患者皮肤镇痛起效时间相似。2-氯普鲁卡因导致的镇痛不全或不足发生率显著更高。分娩结束时需要产钳助产的产妇数量,布比卡因组(n = 25,40%)与2-氯普鲁卡因组(n = 11,28%)无统计学差异(χ² = 1.5971,p = 0.2063)。两组中需要产钳助产的产妇第二产程显著更长。这些患者使用的局部麻醉药也显著更多。所有新生儿在出生后3分钟内进行阿氏评分。除布比卡因组1例之外,所有观察到的阿氏评分均超过8分。采集脐血测定pH值。布比卡因组(7.314±0.106)脐血pH值略低于但显著低于2-氯普鲁卡因组(7.345±0.06)(t = 1.6968,p = 0.046)。母亲接受布比卡因硬膜外镇痛后产钳助产娩出的新生儿脐血pH值(7.278±0.117)显著低于布比卡因组中无需产钳助产的新生儿(7.337±0.093)(t = 2.1986,p = 0.0159)。(摘要截选至250词)